Skip to main content
OpenTrials

Clinical trial condition

Hyperparathyroidism, Secondary

Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.

148 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Hyperparathyroidism, Secondary trial results

Completed

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

NCT02274623

Conditions
Bone Diseases, Bone Neoplasms, Breast Cancer, +25 more
Locations
  • Coast Hematology-Oncology Associates Long Beach, California, United States
  • Mount Sinai Medical Center, Comprehensive Cancer Center Miami, Florida, United States
  • Research by Design LLC Evergreen Park, Illinois, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

NCT01785849

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Azusa, California, United States
  • Research Site Covina, California, United States
View all 118 locations
View Trial Details
Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

NCT01788046

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Azusa, California, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Chula Vista, California, United States
View all 106 locations
View Trial Details
Completed

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

NCT01896232

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Research Site Azusa, California, United States
  • Research Site Bakersfield, California, United States
  • Research Site Bakersfield, California, United States
  • Research Site Chula Vista, California, United States
View all 182 locations
View Trial Details
Completed

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

NCT02833857

Conditions
Chronic Disease, Chronic Kidney Disease, Secondary Hyperparathyroidism, Disease Attributes, +14 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site Kansas City, Missouri, United States
  • Research Site Brussels, Belgium
View all 13 locations
View Trial Details
Completed

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

NCT01785875

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Azusa, California, United States
  • Research Site Bakersfield, California, United States
View all 208 locations
View Trial Details
Completed

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

NCT01939977

Conditions
Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations
  • Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Barcelona, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Complexo Hospitalario Universitario A Coruna A Coruña, Spain
View all 16 locations
View Trial Details
Completed

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

NCT01932970

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Alhambra, California, United States
  • Research Site Azusa, California, United States
  • Research Site Bakersfield, California, United States
  • Research Site Chula Vista, California, United States
View all 40 locations
View Trial Details

Related conditions